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maternal iodine supplementation policy
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Utsana Tonmukayakul, Román Pérez Velasco*, Sripen Tantivess and Yot TeerawattananonAbstract
In this paper, the authors share their experience on evidence utilization in the development of Thailand’s maternal
iodine supplementation policy in 2009–2010. Observations and reflections on their experience of engaging with
research for policymaking are illustrated. The case study indicates that rapid approaches in conducting research,
namely a targeted literature review and cross-sectional survey of professionals’ opinions and current practices were
efficient in achieving the timeliness of evidence provision. In addition pro-activity, trust and interaction between
researchers and policymakers enhanced the research–policy integration. The Thai experience may be useful for
other developing countries which pursue evidence-informed policymaking, despite differences in the health system
context.
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Research utilization in policymaking
Recently, there has been a greater attention to evidence-
informed policymaking and the transparency, account-
ability and inclusiveness of its processes [1]. Although
prioritization of research topics and systematic reviews/
randomized control trials are considered the best
approaches to select and generate evidence, sometimes
more rapid approaches to gather information are needed
due to cost considerations, limited human resources,
and urgent demands [2].
Systematic reviews and primary studies of health re-
search utilization have revealed that there are a number
of factors influencing research utilization. These include:
(a) interaction and trust between decision-makers and
researchers; (b) the quality, timeliness and relevance of
the evidence produced; (c) the political environment; (d)
the attitude and proficiency of decision-makers; (e)
established policy networks; (f ) the concurrence of* Correspondence: romanperezvelasco@gmail.com
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distribution, and reproduction in any mediumresearch findings with existing policies, and (g) the social
and economic environment [3–6].Iodine deficiency disorders in Thailand
Iodine deficiency disorders (IDD) remain an important
health problem in Thailand, even though several initia-
tives have been carried out by the Ministry of Public
Health (MoPH) in collaboration with international and
domestic organizations for decades. Since the establish-
ment of the National IDD Control Board in 1994, three
major measures—Universal Salt Iodization (USI), iodized
oil capsules and water iodization—have been introduced.
Despite these initiatives, mild to moderate IDD and its
consequences still exist [7]. An external review con-
ducted by the International Council for Control of Iod-
ine Deficiency Disorders (ICCIDD) in 2009 indicated the
ineffectiveness of the USI and suboptimal iodine nutri-
tion in 60–70% of pregnant Thai women [8]. The dis-
semination of the review results, in particular the
information on the declining intellectual quotient in
Thai children, drew the attention of concerned parties
including the MoPH, not only to the problem of chil-
dren’s intelligence but also to its attributable factors and
potential solutions. Providing iodine supplements toCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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measure towards reversing this trend.
Objectives
This paper aims to explore the development of maternal
iodine supplementation policy in Thailand between No-
vember 2009 and October 2010. It sheds light on the
role of scientific evidence and the factors encouraging
the utilization of such evidence in the policy decisions.
The Thai lessons may be helpful for other developing
countries pursuing research–policy nexus in their own
health system context.
Researchers’ role in policy process and evidence
generation
1. To understand the policy process and identify the
factors influencing evidence uptake, observation of
stakeholder consultations and a review of
government documents, internal circulars, and e-
mail communication were employed.
2. To address particular policy questions, the authors
conducted a rapid review on the evidence on
appropriate dosage and forms of iodine, and a rapid
survey of obstetricians’ current practices,
perceptions and preferred formulation of
micronutrient supplements.
Observations and reflections on the experience of
research utilization
Timeline of key events
The development of the maternal iodine supplementa-
tion policy occurred within one year after the findings of
the ICCIDD’s review were publicised, as depicted in
Figure 1. Key actors are presented in ovals, important
events in boxes, and evidence provided in rounded
rectangles.
The attention of the Thai government was seriously
stimulated in November 2009 when this problematic
issue was raised on the meeting agenda of the National
Committee on Early Childhood Development (NCECD)
[9]. The Committee requested that the MoPH introduce
an iodine supplementation program for pregnant
women. While this policy was generally agreed upon in
principle by most stakeholders, there were questions
over the appropriate dosage and formulation of the iod-
ine supplements. In this respect, the Department of
Health (DoH) and the Royal Thai College of Obstetri-
cians and Gynecologists (RTCOG) suggested the
provision of a multinutrient preparation.
It was not until March 2010 that the MoPH officially
announced that it would offer iodine, iron and folic acid
tablets to pregnant women, as well as iodine and iron
supplements for neonates and children under 5 yearsold [10]. This initiative received support from the World
Health Organization (WHO) and the United Nations
Children’s Fund’s (UNICEF) officers in Thailand as the
iodine supplement would ensure adequate iodine intake
by pregnant and lactating women. Local representatives
of the WHO and UNICEF also strongly recommended
that the MoPH strengthen the USI program [11, 12].
Devising a policy instrument
However, the new initiative could not get started. Since
iodine supplements were not included in the country’s
pharmaceutical benefit package, the National List of
Essential Medicines (NLEM) [13], the products could
not be subsidised in public health schemes. In response
to the obstacle, in April 2010 the NLEM Development
Committee decided to list iodized oil capsules for mater-
nal use, rather than the multinutrient preparations pro-
posed by the DoH. The three underlying reasons for the
decision were: i) a concern for excessive intake of vita-
min A during pregnancy (WHO safety limits 10,000 IU),
ii) the possibility of overconsumption of unnecessary
micronutrients, and iii) the fact that iodized oil capsules
were listed in the WHO’s Model List of Essential Medi-
cines. Whereas the DoH and RTCOG argued that a mul-
tinutrient preparation would satisfy the nutritional
requirements in pregnancy and treatment adherence,
both the NLEM and the Universal Coverage Committees
rejected this proposal due to the inconclusive evidence.
The debate continued in three consultations chaired
by the MoPH’s Permanent Secretary between June and
August 2010. The discussions focused on the most ap-
propriate iodine preparations to be offered to pregnant
and lactating women. Throughout the consultation pro-
cesses, several types of evidence were provided by re-
spective organizations. The DoH prepared a list of
multinutrient products available in the country, along
with a concept note highlighting the crucial roles of folic
acid, iodine and iron in child development, as well as
the prevalence of iron deficiency anemia and thalassemic
pregnancy cases (thalassemia remains an important
health problem [14]).
With regards to iodized oil, this formulation was
removed from the NLEM in September 2010 because
of health professionals’ concerns about potential hyper-
thyroidism as the preparation was going to be pre-
scribed in a mild-to-moderate iodine deficient setting
like Thailand [8].
The quest for an appropriate preparation
Shortly after, it was concluded that the maternal supple-
ment would only contain folic acid, iodine and iron. The
discussion was then geared towards the question of
which formulations and dosages should be offered. The
options ranged from a combination of the three
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Figure 1 Timeline of key policy development events (November 2009 – October 2010).
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researchers from the Health Intervention and Technol-
ogy Assessment Program (HITAP), a semi-autonomous
research agency under the aegis of the MoPH [15], ac-
tively provided evidence synthesized from systematic
reviews, clinical trials, guidelines and documents about
dosage and formulations for maternal iodine supplemen-
tation. Reference lists were scanned, authors of ongoing
clinical trials were contacted, and relevant experts were
consulted (see Additional file 1).
HITAP had been requested to verify the appropriate-
ness of iodine supplementation, even though this topic
was not selected through the conventional prioritization
channels. This is because of the trust and interactive re-
lationship built with key policymakers since the agency’s
inception [15, 16]. Owing to this relationship, HITAP
researchers were able to actively share evidence to ad-
dress questions arising during the deliberations. Also,
HITAP proposed to conduct a rapid preference survey
among the 2,228 RCOGT members in September 2010
[17] (see Additional file 2).
Drawn from the abovementioned evidence, HITAP
recommended a fixed-dose combination of the three
nutrients for the target population, and potassium iodide
in a single tablet for thalassemic pregnant women. Sug-
gested doses were based on the daily requirements
recommended by the WHO and UNICEF - 400 μg of
folic acid, 250 μg of iodine, and 60 μg of iron [18]. Given
the current movement to strengthen the USI program,
however, some experts suggested that 150 μg was safer
than 250 μg of iodine. The Government PharmaceuticalOrganization (GPO), a state enterprise under the MoPH
[19], was assigned to produce and distribute both pre-
parations. On 1 October 2010, the maternal iodine sup-
plementation program was inaugurated nationwide.
Discussion and lessons drawn
As suggested in this case study, the decision on the
provision of the iodine supplement was made from in-
ception, while evidence from a rapid review and survey
played a crucial role in addressing the need for timely
evidence on the most suitable iodine-containing
preparation.
Rapid reviews and syntheses of selected pieces of in-
formation are commonly conducted in response to pres-
sure from decision-makers who frequently need to make
decisions in short time periods [2]. Although questions
have arisen regarding the appropriateness and transpar-
ency of these methodologies in comparison to full
reviews, it has been argued that they can still play an im-
portant role in evidence-informed decision-making, and
emphasis should be placed on their appropriate use [20].
Evidence has shown that the results of rapid and full
reviews are not much different, although the scope of
the former is narrower [21]. Since the evidential needs
of the iodine case deliberations were specifically related
to appropriate formulation and dosage, a rapid review
appears to be a suitable approach to support policy-
making in this instance.
Given the short time available for conducting the sur-
vey, the exclusion of non-RTCOG practitioners such as
nurses, midwives, and family physicians, all of whom
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nal iodine supplement prescribers are not perfectly
represented. However, specialist physicians have a high
influence on other health professionals and patients in
Thailand [22, 23]; therefore, the survey targeted this
group in order to engage them in the future policy
implementation.
In addition, the right timing and timeliness of providing
research results is critical to foster research utilization as
argued in Lavis et al. [4]. In the same vein, this case study
suggests that HITAP researchers were able to provide
relevant evidence to policymakers and key stakeholders in
a timely fashion. This paper also reveals that the pro-
active identification of evidence requirements during on-
going policy processes might be a key factor facilitating
evidence uptake and strengthening trust and interactive
relationships between policymakers and researchers.
Additional file
Additional file 1. Summary of the rapid review results
Additional file 2. Summary of the rapid survey results
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